ArticleOrthopaedic surgery2026
Impact of Preoperative Non-Collapse and Collapse Durations on Total Hip Arthroplasty Outcomes in Nontraumatic Osteonecrosis of the Femoral Head.
Article in Orthopaedic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundCurrent clinical strategies emphasize delaying total hip arthroplasty (THA) in patients with nontraumatic osteonecrosis of the femoral head (NONFH). However, it remains unknown whether prolonged abnormal joint mechanics during this delayed period compromise the final surgical outcomes. Consequently, the impact of the prolonged collapsed or non-collapsed hip joint stages on THA efficacy has not yet been evaluated. This study aimed to analyze the effect of the duration of a collapsed or non-collapsed hip joint on the efficacy of subsequent THA.
methodsThis retrospective cohort study included 111 NONFH patients who underwent primary unilateral THA between June 2022 and June 2023. Patients were grouped based on the duration of their non-collapsed or collapsed stages (≤ 1 year, 1-3 years, and > 3 years) prior to surgery. Postoperative outcome measures, including the numerical rating scale (NRS) for pain and the Harris Hip Score (HHS) for hip function, were obtained through video-call follow-up. Statistical analyses included ANOVA, Kruskal-Wallis H tests, multivariable GLM, and ROC curve analysis.
resultsA total of 111 patients were ultimately included in this study. Significant differences were found between the Joint Surface Non-Collapse Group and the Survival with Collapse Group regarding whether they had received oral medication treatment (p < 0.05). Patients with different survival durations of collapse demonstrated significant differences in ARCO staging at the time of final THA (p < 0.05). Postoperatively, significant differences in NRS scores were observed among patients with different survival durations of collapse (p < 0.05), with the 1-3 year collapse group reporting higher pain scores compared to the > 3 year group. However, multivariable GLM revealed that preoperative duration did not independently predict the final absolute HHS (p > 0.05), indicating an equalizing trend of THA across all groups. Notably, the duration of collapse independently predicted postoperative pain, with the 1-3 year group exhibiting significantly worse NRS scores (p = 0.023).
conclusionWhile THA provides highly effective and equalized functional recovery regardless of the preoperative duration of the collapsed or non-collapsed stages, surgical timing significantly impacts postoperative pain. Operating during the 1-3 year post-collapse window is an independent risk factor for inferior pain relief. Given the limited subgroup sizes, these exploratory findings warrant further multicenter validation. LEVEL OF EVIDENCE: Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.